Position in FOLD
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$5,784
+$88 QoQ
Shares Held
400
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CALDWELL SUTTER CAPITAL, INC. holds $221,639 across 17 Biotechnology names. FOLD ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,000 | $148,520 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
432 | $25,103 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
300 | $19,389 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21 | $9,377 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
400 | $5,784 | |
| 6 | LPCN |
Lipocine Inc.
|
471 | $3,763 | |
| 7 | PRLD |
Prelude Therapeutics Inc
|
1,000 | $3,420 | |
| 8 | ATAI |
AtaiBeckley Inc.
|
700 | $2,478 |
All Filings in FOLD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,784 | 400 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,696 | 400 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,152 | 400 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,890 | 330 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,692 | 330 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,108 | 330 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,524 | 330 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,273 | 330 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $3,887 | 330 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $4,682 | 330 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $4,012 | 330 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $4,144 | 330 | Shares | Sole | 2023-07-19 | |
| No filing history on record for this holder in this stock. | ||||||